Black Diamond Therapeutics, Inc.(BDTX)
Biotechnology
Oncology Biotech
Recent Insider Trades
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-03-20 | BB BIOTECH AG 10% Owner | Sale | -5,784,292 | -67.91%2,733,547 | $2.07 | $11,997,749 | View SEC filing | |
| 2024-08-30 | Versant Venture Capital VI, L.P. 10% Owner | Sale | -221,600 | -5.61%3,726,341 | $6.32 | $1,400,556 | View SEC filing | |
| 2023-10-19 | BB BIOTECH AG 10% Owner | Purchase | +400,000 | +4.93%8,517,839 | $2.34 | $934,080 | View SEC filing | |
| 2023-07-07 | RA Capital Healthcare Fund LP Director | Purchase | +935,850 | +41.08%3,213,828 | $5.00 | $4,679,250 | View SEC filing | |
| 2023-07-06 | Behbahani Ali Director | Purchase | +1,000,000 | +29.00%4,448,757 | $5.00 | $5,000,000 | View SEC filing | |
| 2023-07-03 | BB BIOTECH AG 10% Owner | Purchase | +1,000,000 | +14.05%8,117,839 | $5.00 | $5,000,000 | View SEC filing | |
| 2023-06-29 | BB BIOTECH AG 10% Owner | Purchase | +1,740,000 | +32.36%7,117,839 | $5.49 | $9,555,036 | View SEC filing | |
| 2023-06-28 | Epstein David M. SEE REMARKS | Sale | -25,000 | -2.60%936,569 | $6.70 | $167,500 | View SEC filing | |
| 2022-12-23 | Ni Fang SEE REMARKS | Purchase | +56,363 | +81.65%125,389 | $1.28 | $72,366 | View SEC filing | |
| 2022-11-02 | BB BIOTECH AG 10% Owner | Purchase | +99,801 | +1.89%5,377,839 | $2.25 | $224,912 | View SEC filing | |
| 2022-10-31 | BB BIOTECH AG 10% Owner | Purchase | +364,652 | +7.42%5,278,038 | $2.02 | $736,186 | View SEC filing | |
| 2022-10-25 | BB BIOTECH AG 10% Owner | Purchase | +87,850 | +1.82%4,913,386 | $1.51 | $132,750 | View SEC filing | |
| 2022-10-21 | BB BIOTECH AG 10% Owner | Purchase | +131,423 | +2.80%4,825,536 | $1.36 | $179,120 | View SEC filing | |
| 2022-06-30 | Ni Fang SEE REMARKS | Purchase | +25,000 | +56.78%69,026 | $2.44 | $61,018 | View SEC filing | |
| 2022-04-29 | BB BIOTECH AG 10% Owner | Purchase | +405,711 | +9.46%4,694,113 | $2.61 | $1,057,348 | View SEC filing | |
| 2022-04-20 | BB BIOTECH AG 10% Owner | Purchase | +300,000 | +7.52%4,288,402 | $3.27 | $980,580 | View SEC filing | |
| 2022-04-14 | BB BIOTECH AG 10% Owner | Purchase | +252,556 | +6.76%3,988,402 | $3.48 | $879,817 | View SEC filing | |
| 2021-05-13 | Hatzis-Schoch Brent See Remarks | Sale | -4,078 | -32.68%8,400 | $27.42 | $111,805 | View SEC filing | |
| 2021-05-05 | Roberts Christopher D. Chief Scientific Officer | Sale | -2,500 | -43.86%3,200 | $26.64 | $66,602 | View SEC filing | |
| 2021-04-13 | Hatzis-Schoch Brent See Remarks | Sale | -4,078 | -32.68%8,400 | $25.00 | $101,950 | View SEC filing | |
| 2021-04-07 | Roberts Christopher D. Chief Scientific Officer | Sale | -2,500 | -43.86%3,200 | $25.54 | $63,848 | View SEC filing | |
| 2021-03-16 | Hatzis-Schoch Brent See Remarks | Sale | -4,078 | -32.68%8,400 | $26.36 | $107,493 | View SEC filing | |
| 2021-03-04 | Roberts Christopher D. Chief Scientific Officer | Sale | -2,500 | -43.86%3,200 | $26.10 | $65,262 | View SEC filing | |
| 2021-02-12 | Hatzis-Schoch Brent See Remarks | Sale | -4,078 | -32.68%8,400 | $27.23 | $111,025 | View SEC filing | |
| 2021-02-04 | Roberts Christopher D. Chief Scientific Officer | Sale | -2,500 | -43.86%3,200 | $25.35 | $63,375 | View SEC filing |
1-25 of 80
Page 1 of 4